{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35972202",
  "DateCompleted": {
    "Year": "2022",
    "Month": "09",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "09",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "08",
        "Day": "16"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1021/acs.analchem.2c01993"
    ],
    "Journal": {
      "ISSN": "1520-6882",
      "JournalIssue": {
        "Volume": "94",
        "Issue": "37",
        "PubDate": {
          "Year": "2022",
          "Month": "Sep",
          "Day": "20"
        }
      },
      "Title": "Analytical chemistry",
      "ISOAbbreviation": "Anal Chem"
    },
    "ArticleTitle": "SCORe: SARS-CoV-2 Omicron Variant RBD-Binding DNA Aptamer for Multiplexed Rapid Detection and Pseudovirus Neutralization.",
    "Pagination": {
      "StartPage": "12683",
      "EndPage": "12690",
      "MedlinePgn": "12683-12690"
    },
    "Abstract": {
      "AbstractText": [
        "During the COVID-19 (coronavirus disease 2019) pandemic, several SARS-CoV-2 variants of concern emerged, including the Omicron variant, which has enhanced infectivity and immune invasion. Many antibodies and aptamers that bind the spike (S) of previous strains of SARS-CoV-2 either do not bind or bind with low affinity to Omicron S. In this study, we report a high-affinity <b>S</b>ARS-<b>C</b>oV-2 <b>O</b>micron <b>R</b>BD-binding aptam<b>e</b>r (SCORe) that binds Omicron BA.1 and BA.2 RBD with nanomolar <i>K</i><sub>D1</sub>. We employ aptamers SCORe.50 and SNAP4.74 in a multiplexed lateral flow assay (LFA) to distinguish between Omicron and wild-type S at concentrations as low as 100 pM. Finally, we show that SCORe.50 and its dimerized form SCOReD can neutralize Omicron S-pseudotyped virus infection of ACE2-overexpressing cells by >70%. SCORe therefore has potential applications in COVID-19 rapid diagnostics as well as in viral neutralization."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States."
          }
        ],
        "LastName": "Yang",
        "ForeName": "Lucy F",
        "Initials": "LF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States."
          }
        ],
        "LastName": "Kacherovsky",
        "ForeName": "Nataly",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States."
          }
        ],
        "LastName": "Liang",
        "ForeName": "Joey",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195, United States."
          }
        ],
        "LastName": "Salipante",
        "ForeName": "Stephen J",
        "Initials": "SJ"
      },
      {
        "Identifier": [
          "0000-0003-1443-4996"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States."
          }
        ],
        "LastName": "Pun",
        "ForeName": "Suzie H",
        "Initials": "SH"
      }
    ],
    "GrantList": [
      {
        "GrantID": "U01 AA029316",
        "Acronym": "AA",
        "Agency": "NIAAA NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U24 LM013755",
        "Acronym": "LM",
        "Agency": "NLM NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Anal Chem",
    "NlmUniqueID": "0370536",
    "ISSNLinking": "0003-2700"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Aptamers, Nucleotide"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aptamers, Nucleotide"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA Viruses"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}